Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA.
Justin Y A DoritchamouMorten A NielsenArnaud ChêneNicola K ViebigLynn E LambertAdam F SanderJean-Philippe SemblatSophia HundtSachy Orr-GonzalezChristoph Mikkel JanitzekAlicia J SpiegelStine B ClemmensenMarvin L ThomasMartha C NasonMaryonne Snow-SmithEmma K BarnafoJoseph ShiloachBeth B ChenSteven NadakalKendrick HighsmithTarik OuahesSolomon ContehAnkur SharmaHolly ToranoBrandi ButlerKarine ReiterKelly M RauschPuthupparampil V ScariaCharles AndersonDavid L NarumAli SalantiMichal FriedThor G TheanderBenoit GamainPatrick Emmet DuffyPublished in: Lab animal (2023)
Placental malaria vaccines (PMVs) are being developed to prevent severe sequelae of placental malaria (PM) in pregnant women and their offspring. The leading candidate vaccine antigen VAR2CSA mediates parasite binding to placental receptor chondroitin sulfate A (CSA). Despite promising results in small animal studies, recent human trials of the first two PMV candidates (PAMVAC and PRIMVAC) generated limited cross-reactivity and cross-inhibitory activity to heterologous parasites. Here we immunized Aotus nancymaae monkeys with three PMV candidates (PAMVAC, PRIMVAC and ID1-ID2a_M1010) adjuvanted with Alhydrogel, and exploited the model to investigate boosting of functional vaccine responses during PM episodes as well as with nanoparticle antigens. PMV candidates induced high levels of antigen-specific IgG with significant cross-reactivity across PMV antigens by enzyme-linked immunosorbent assay. Conversely, PMV antibodies recognized native VAR2CSA and blocked CSA adhesion of only homologous parasites and not of heterologous parasites. PM episodes did not significantly boost VAR2CSA antibody levels or serum functional activity; nanoparticle and monomer antigens alike boosted serum reactivity but not functional activities. Overall, PMV candidates induced functional antibodies with limited heterologous activity in Aotus monkeys, similar to responses reported in humans. The Aotus model appears suitable for preclinical downselection of PMV candidates and assessment of antibody boosting by PM episodes.
Keyphrases
- plasmodium falciparum
- particulate matter
- air pollution
- endothelial cells
- pregnant women
- high glucose
- heavy metals
- polycyclic aromatic hydrocarbons
- dendritic cells
- diabetic rats
- induced pluripotent stem cells
- drug induced
- dna damage
- pluripotent stem cells
- oxidative stress
- stem cells
- immune response
- metabolic syndrome
- dna repair
- high throughput
- cystic fibrosis
- mass spectrometry
- tandem mass spectrometry